Anzupgo LEO Pharma Pty Ltd
Product name
Anzupgo
Sponsor
Accepted date
Jan-2025
Active ingredients
delgocitinib
Proposed indication
ANZUPGO (Delgocitinib) is indicated for the treatment of chronic hand eczema in adults.
Application type
A (new medicine)
Publication date
Jan-2025